European journal of hospital pharmacy : science and practice最新文献

筛选
英文 中文
Importance of ambient temperature on the efficacy of elastomeric infusion pumps. 环境温度对弹性输液泵功效的影响。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-17 DOI: 10.1136/ejhpharm-2024-004368
Sara Ferro Rodríguez, Arón Misa García
{"title":"Importance of ambient temperature on the efficacy of elastomeric infusion pumps.","authors":"Sara Ferro Rodríguez, Arón Misa García","doi":"10.1136/ejhpharm-2024-004368","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004368","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neutropenia possibly caused by cefoperazone/sulbactam. 中性粒细胞减少症可能由头孢哌酮/舒巴坦引起。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-17 DOI: 10.1136/ejhpharm-2024-004188
Yun Li, Xiao Fang He, Ran Wang
{"title":"Neutropenia possibly caused by cefoperazone/sulbactam.","authors":"Yun Li, Xiao Fang He, Ran Wang","doi":"10.1136/ejhpharm-2024-004188","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004188","url":null,"abstract":"<p><p>Neutropenia is a rare complication of drug therapy and is usually underdiagnosed. Cefoperazone/sulbactam is a combination of broad-spectrum antibacterial agents. Data on cefoperazone/sulbactam-induced neutropenia are limited. Herein, we report the case of a 35 year-old female patient who was admitted to the hospital due to an appendiceal abscess. After anti-infective treatment with cefoperazone/sulbactam, the patient developed neutropenia on day 4. After discontinuing treatment with cefoperazone/sulbactam, the patient's white blood cells and neutrophils gradually returned to normal. Hence, clinicians should monitor changes in neutrophil count during cefoperazone/sulbactam therapy and provide timely treatment.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge. 大麻剧吐综合征:新出现的临床和公共卫生挑战。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-15 DOI: 10.1136/ejhpharm-2024-004369
Aron Misa Garcia, Sara Ferro Rodríguez
{"title":"Cannabis hyperemesis syndrome: an emerging clinical and public health challenge.","authors":"Aron Misa Garcia, Sara Ferro Rodríguez","doi":"10.1136/ejhpharm-2024-004369","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004369","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the capabilities of advanced large language models in generating patient instructions and patient educational material. 研究先进的大型语言模型在生成患者指南和患者教育材料方面的能力。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-11 DOI: 10.1136/ejhpharm-2024-004245
Kannan Sridharan, Gowri Sivaramakrishnan
{"title":"Investigating the capabilities of advanced large language models in generating patient instructions and patient educational material.","authors":"Kannan Sridharan, Gowri Sivaramakrishnan","doi":"10.1136/ejhpharm-2024-004245","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004245","url":null,"abstract":"<p><strong>Objectives: </strong>Large language models (LLMs) with advanced language generation capabilities have the potential to enhance patient interactions. This study evaluates the effectiveness of ChatGPT 4.0 and Gemini 1.0 Pro in providing patient instructions and creating patient educational material (PEM).</p><p><strong>Methods: </strong>A cross-sectional study employed ChatGPT 4.0 and Gemini 1.0 Pro across six medical scenarios using simple and detailed prompts. The Patient Education Materials Assessment Tool for Print materials (PEMAT-P) evaluated the understandability, actionability, and readability of the outputs.</p><p><strong>Results: </strong>LLMs provided consistent responses, especially regarding drug information, therapeutic goals, administration, common side effects, and interactions. However, they lacked guidance on expiration dates and proper medication disposal. Detailed prompts yielded comprehensible outputs for the average adult. ChatGPT 4.0 had mean understandability and actionability scores of 80% and 60%, respectively, compared with 67% and 60% for Gemini 1.0 Pro. ChatGPT 4.0 produced longer outputs, achieving 85% readability with detailed prompts, while Gemini 1.0 Pro maintained consistent readability. Simple prompts resulted in ChatGPT 4.0 outputs at a 10th-grade reading level, while Gemini 1.0 Pro outputs were at a 7th-grade level. Both LLMs produced outputs at a 6th-grade level with detailed prompts.</p><p><strong>Conclusion: </strong>LLMs show promise in generating patient instructions and PEM. However, healthcare professional oversight and patient education on LLM use are essential for effective implementation.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication stability: from pharmacies to patients' homes-is consistent storage achievable? 药物稳定性:从药房到患者家中--能否实现一致的储存?
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-10 DOI: 10.1136/ejhpharm-2024-004365
Alessio Provenzani, Salvatore Di Maria
{"title":"Medication stability: from pharmacies to patients' homes-is consistent storage achievable?","authors":"Alessio Provenzani, Salvatore Di Maria","doi":"10.1136/ejhpharm-2024-004365","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004365","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stability of clozapine tablets repackaged in dose administration aids using repackaging machines. 使用重新包装机将氯氮平片剂重新包装在给药辅助工具中的稳定性。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-07 DOI: 10.1136/ejhpharm-2023-004036
Marion Emonet, Antony Citterio-Quentin, Sandrine Bourgeois, Vanessa Godard, Clément Boidin, Cynthia Barratier, Jonathan Boisramé
{"title":"Stability of clozapine tablets repackaged in dose administration aids using repackaging machines.","authors":"Marion Emonet, Antony Citterio-Quentin, Sandrine Bourgeois, Vanessa Godard, Clément Boidin, Cynthia Barratier, Jonathan Boisramé","doi":"10.1136/ejhpharm-2023-004036","DOIUrl":"10.1136/ejhpharm-2023-004036","url":null,"abstract":"<p><strong>Background: </strong>The use of dose administration aids in automated ward dispensing devices requires the repackaging of medications, which may impact their stability compared with the original manufacturer's packaging.</p><p><strong>Objectives: </strong>This study aimed to assess the physical and chemical stability of clozapine tablets for up to 84 days after repackaging.</p><p><strong>Methods: </strong>A total of 900 tablets of clozapine 100 mg (Viatris) were repackaged and stored under five different conditions to conduct physical and chemical stability tests on days 0, 28, 56 and 84. The results were compared with control tablets in their original packaging. Visual inspections of tablet appearance were performed. Physical tests included assessments of mass uniformity, friability and resistance to crushing, following the standards of the European Pharmacopoeia 11th edition. The chemical stability was determined using ultra-high performance liquid chromatography with tandem-mass spectrometry detection (UHPLC-MS/MS) to measure clozapine concentration, N-desmethyl-clozapine, and monitor clozapine degradation to detect formation of any degradation products other than N-desmethyl-clozapine.</p><p><strong>Results: </strong>Visual examination showed changes in the appearance of tablets only in those stored under UV light. Mass uniformity met standards for all tablets over 84 days. None passed the friability test due to tablet cracking after tumbling. A gradual deterioration in tablet hardness was observed with the resistance to crushing test. In terms of chemical stability, N-desmethyl-clozapine was undetected in any of the tablets stored under all conditions, and the mean concentration of clozapine remained within the target range over 84 days.</p><p><strong>Conclusion: </strong>N-desmethyl-clozapine was not detected and clozapine concentrations remained stable under all storage conditions. The tablets were compliant with the mass uniformity test in each condition. However, the tablets were cracked in the friability test and gradual deterioration in tablet hardness was observed. In the light of these results, the Vinatier Hospital pharmacy has chosen to establish a shelf life for clozapine tablets of 84 days.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A single harmonised pharmacy process to improve clinical trial set-up times. 统一药房流程,缩短临床试验准备时间。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-10-03 DOI: 10.1136/ejhpharm-2024-004215
Miriam Lettieri, Sophia Boydell, Andreea Chivu, Sarah Fallon, Andrew Ustianowski, Monika Cien, Claire Cole, Sophia Burgess, Carolyn Davies, Claire Keatley, Anne-Marie Peers, Maxine Syme, Deborah Sutton, Nicola Hermitage, Lydia Sutherland, Michelle Beecroft, Ali Aghabeigi, Beatriz Duran Jimenez
{"title":"A single harmonised pharmacy process to improve clinical trial set-up times.","authors":"Miriam Lettieri, Sophia Boydell, Andreea Chivu, Sarah Fallon, Andrew Ustianowski, Monika Cien, Claire Cole, Sophia Burgess, Carolyn Davies, Claire Keatley, Anne-Marie Peers, Maxine Syme, Deborah Sutton, Nicola Hermitage, Lydia Sutherland, Michelle Beecroft, Ali Aghabeigi, Beatriz Duran Jimenez","doi":"10.1136/ejhpharm-2024-004215","DOIUrl":"10.1136/ejhpharm-2024-004215","url":null,"abstract":"<p><p>The UK has fallen from fourth to 10th place in the global ranking for clinical trial activities in the past 6 years. Due to the limited capacity of the clinical trial pharmacy workforce and delays in providing pharmacy approvals, pharmacy has been identified as one of the constraining services that delays the set-up and delivery of clinical trials. To tackle this problem, we developed a single pharmacy review process for multicentre trials across Greater Manchester (GM) and tested its feasibility and implementation in our region. A survey completed by each GM Trust suggests that this harmonised pharmacy review process for multicentre studies would expedite trial set-up time at each pharmacy site and standardise the pharmacy review process in GM. We therefore believe that this harmonised review process could potentially reduce pharmacy set-up time and reposition the UK in the global market for clinical trials.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141467139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse drug reactions in paediatric age: analysis of spontaneous reports and reasons for under-reporting in a Local Health Unit in Veneto region. 儿科药物不良反应:威尼托大区一家地方医疗单位的自发报告分析及报告不足的原因。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-09-30 DOI: 10.1136/ejhpharm-2024-004335
Eva Draghi, Virginia De Rossi, Umberto Gallo, Riccardo Bertin, Francesca Bano
{"title":"Adverse drug reactions in paediatric age: analysis of spontaneous reports and reasons for under-reporting in a Local Health Unit in Veneto region.","authors":"Eva Draghi, Virginia De Rossi, Umberto Gallo, Riccardo Bertin, Francesca Bano","doi":"10.1136/ejhpharm-2024-004335","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004335","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations. 比较医院药房对非肠道注射剂产品的目视检查方法:可靠性、成本和操作员形成之间的考虑因素。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-09-30 DOI: 10.1136/ejhpharm-2024-004143
Alexandre Jambon, Marie Forat, Chloé Marchand, Corinne Morel, Camille Merienne, Samira Filali, Fabrice Pirot
{"title":"Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.","authors":"Alexandre Jambon, Marie Forat, Chloé Marchand, Corinne Morel, Camille Merienne, Samira Filali, Fabrice Pirot","doi":"10.1136/ejhpharm-2024-004143","DOIUrl":"10.1136/ejhpharm-2024-004143","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic has led to unforeseen and novel manifestations, as illustrated by the management of drug shortages through the development of hospital production of sterile pharmaceutical preparations (P2S). Visual inspection of P2S is a release control whose methods are described in monographs of the European Pharmacopoeia (2.9.20) and the United States Pharmacopeia (1790). However, these non-automated visual methods require training and proficiency testing of personnel. The main objective of this work was to compare the reliability and speed of analysis of two visual methods and an automated method for detecting visible particles by image analysis in P2S. Furthermore, these methods were used to evaluate sources of particulate contamination during pre-production processes (washing, disinfection, depyrogenation) and production (filling, capping).</p><p><strong>Materials and methods: </strong>Three pharmacy technicians examined 41 clear glass vials of type I, 10 and/or 50 mL through manual visual inspection (MVI), semi-automated (SAVI), and automated (AVI) inspection. The vials were distributed as follows: (i) 16 vials of water for injection containing either glass particles (224 µm or 600 µm), stopper fragments, or textile fibres; (ii) five sterile injectable specialties; (iii) 20 vials of water for injection prepared under different pre-production conditions.</p><p><strong>Results and discussion: </strong>MVI and SAVI detected 100% of visible particles compared with 28% for AVI, which showed a deficiency in detecting textile fibres. All three methods correctly analysed P2S that did not contain visible particles. The three methods detected particles in vials maintained under International Organization for Standardization (ISO) 9 pre-production conditions. However, detections by (i) MVI and SAVI, and by (ii) AVI of particles contained in vials maintained under ISO 8 pre-production conditions were deemed satisfactory and unsatisfactory, respectively.</p><p><strong>Conclusion: </strong>The importance of visual inspection of P2S requires rapid, sensitive, and reliable detection methods. In this context, MVI and SAVI have proven to be more effective than AVI for a more competitive financial, training, and implementation investment.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141092284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report. 结核病治疗期间头孢曲松诱发血小板减少症:病例报告。
IF 1.6 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2024-09-27 DOI: 10.1136/ejhpharm-2024-004165
Matthijs Plas, Linda M Kampschreur, Johannes A Kroes, Leendert Porcelijn, Carina Bethlehem
{"title":"Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report.","authors":"Matthijs Plas, Linda M Kampschreur, Johannes A Kroes, Leendert Porcelijn, Carina Bethlehem","doi":"10.1136/ejhpharm-2024-004165","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004165","url":null,"abstract":"<p><p>We present a case of drug-induced immune thrombocytopenia (DITP) proven to be due to ceftriaxone instead of assumed tuberculostatic treatment in a patient with miliary tuberculosis. It is important to identify the culprit drug in DITP to avoid discontinuing essential treatment, especially when more than one drug is implicated. In these cases additional analysis (drug-dependent platelet antibody testing) should be considered to prevent unnecessary replacement of a first-line regimen of tuberculostatic treatment with an alternative treatment regime.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信